Longevity Health Holdings, Inc. Deferred Offering Costs
Longevity Health Holdings, Inc. (XAGE) had Deferred Offering Costs of $86.31 thousand as of 2024-12-31, per its 10-K/A filed 2025-06-17.
Financial Statements › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredOfferingCosts · last filed 2025-06-17
- 2024-12-31: Deferred Offering Costs $86.31K.
- 2022-12-31: Deferred Offering Costs $394.15K; Deferred Offering Costs as first filed $1.32M.
| Period end | Deferred Offering Costs | Deferred Offering Costs as first filed |
|---|---|---|
| 2024-12-31 | $86.31K 10-K/A · filed 2025-06-17 | |
| 2022-12-31 | $394.15K 10-K · filed 2024-04-01 | $1.32M 10-Q · filed 2023-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |